DRKS00014339已完成不适用
Oral Anticoagulants in Epistaxis Patients - OAC bei Epistaxis
HNO Klinik,SANA Kliniken Leipziger Land0 个研究点目标入组 540 人开始时间: 2018年5月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 540
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •All patients with a minimum age of 18 years that were treated stationary with the diagnosis epistaxis between 01.01.2011. - 01.01.2018 in the Hospital SANA Kliniken Leipziger Land, Klinikum Borna
排除标准
- •The exclusion criteria were: active malignant disease, known genetic coagulopathy, liver disease and/ or failure, active respiratory infection, perforation of the nasal septum, postoperative bleeding after nasal surgery including septumplasty, septorhinoplasty or sinus surgery
研究者
相似试验
招募中
不适用
Effects of treatment with oral anticoagulant associated with antibiotic therapy in Covid-19Covid-19B04.820.578.500.540.150RBR-7nzwkpgniversidade do Sul de Santa Catarina
尚未招募
不适用
ew Oral Anticoagulants (NOAC) Study: Investigation of laboratory tests an development of a gold standard test for monitoring dabigatran and rivaroxaban therapyblood clotthrombosis1000752110014523NL-OMON39575Catharina-ziekenhuis120
已完成
不适用
Treatment with new oral anticoagulants in primary care practicesI48Atrial fibrillation and flutterDRKS00006862niversitätsklinikum Bonn353
尚未招募
不适用
Oral Anticoagulation Monotherapy After Endovascular Therapy for Peripheral Artery Disease in Patients Requiring AnticoagulatioPeripheral artery diseaseJPRN-UMIN000040985Hyogo College of Medicine40
进行中（未招募）
不适用
Comparison among two drugs commonly used in the prevention and treatment of thrombosis, to prevent thromboembolism after total cavopulmonary operation.Hypoplastic right heart syndrome, thrombosis, Tricuspid atresia.Q22.6C14.907.355.830C14.240.400.920RBR-4z9wdgHospital do Coração da Associação do Sanatório Sirio